Inventor · disambiguated record
Jun Tan
Also filed as: TAN JUN · TAN JUN TOWN
19 granted patents·26 pending applications·50 citations·filing 2000–2024
92Inventor score
Top patents by PatentIndex Score
45 records- 0187US8778986B1Treatment of glycogen synthase kinase-based diseaseTAN JUN·Filed 2008·Granted Jul 15, 2014·14 cites·4 claims
- 0280US8906414B1Methods and compositions for improving bioavailability of epigallocatechin gallate (EGCG)SHYTLE ROLAND DOUGLAS·Filed 2010·Granted Dec 9, 2014·7 cites·12 claims
- 0380US7442394B2Combined effects of nutrients on proliferation of stem cellsUNIV SOUTH FLORIDA·Filed 2006·Granted Oct 28, 2008·2 cites·4 claims
- 0477US8802638B1Flavonoid treatment of glycogen synthase kinase-based diseaseTAN JUN·Filed 2009·Granted Aug 12, 2014·3 cites·6 claims
- 0573US8778894B2Luteolin and diosmin/diosmetin as novel STAT3 inhibitors for treating autismTAN JUN·Filed 2013·Granted Jul 15, 2014·3 cites·15 claims
- 0672US9827285B1Compositions and methods of improving cognitive performanceBICKFORD PAULA C·Filed 2014·Granted Nov 28, 2017·2 cites·10 claims
- 0769US8574640B2Combined effects of nutrients on proliferation of stem cellsDAVIS SANBERG CYNDY·Filed 2010·Granted Nov 5, 2013·1 cites·4 claims
- 0868US8008539B1Generation of transgenic human soluble amyloid precursor protein alpha expressing miceUNIV SOUTH FLORIDA·Filed 2010·Granted Aug 30, 2011·5 cites·2 claims
- 0968US2010069479A1Neurodegenerative disease treatment using jak/stat inhibitionUNIV SOUTH FLORIDA·Filed 2009·Application pending·0 cites
- 1066US2024293579A1Composition Comprising Trim31 and Rhbdf2 for Treatment of NAFLD/NASHCHONGQING MEIPULAN TECH CO LTD·Filed 2024·Application pending·0 cites
- 1166US2009280198A1Combined effects of nutrients on proliferation of stem cellsSANBERG CYNDY DAVIS·Filed 2008·Application pending·0 cites
- 1263US10828312B2Lithium cholesterol compositions, including, but not limited to lithium cholesterol sulfate compositions, and methods of treatment for Alzheimer's disease and neurological disordersTAN JUN·Filed 2019·Granted Nov 10, 2020·0 cites·6 claims
- 1362US7052852B1CD45 isoform alteration in CD4+ T cells as a potential diagnostic marker in alzheimer's diseaseROSKAMP RES LLC·Filed 2003·Granted May 30, 2006·5 cites·5 claims
- 1462US2015157597A1Neurodegenerative disease treatment using jak/stat inhibitionTAN JUN·Filed 2014·Application pending·0 cites
- 1557US10039785B2HUCBC treatment of amyloid-associated diseaseTAN JUN·Filed 2016·Granted Aug 7, 2018·0 cites·17 claims
- 1657US2013261045A1Green tea polyphenol alpha secretase enhancers and methods of useUNIV SOUTH FLORIDA·Filed 2012·Application pending·0 cites
- 1756US9238149B2Prevention and treatment of alzheimer'S disease through electromagnetic field exposureARENDASH GARY W·Filed 2011·Granted Jan 19, 2016·2 cites·20 claims
- 1856US2018325950A1Hucbc treatment of amyloid-associated diseaseTAN JUN·Filed 2018·Application pending·0 cites
- 1956US2015153330A1sAPP-alpha as a Biomarker for Prediction of Inflammatory and Autoimmune-Related DisordersTAN JUN·Filed 2014·Application pending·0 cites
- 2055US10098909B2Ionic cocrystal of lithium, lispro, for the treatment of fragile X syndromeTAN JUN·Filed 2017·Granted Oct 16, 2018·0 cites·12 claims
- 2154US2021030770A1Lithium cholesterol compositions, including, but not limited to lithium cholesterol sulfate compositions, and methods of treatment for alzheimer's disease and neurological disordersUNIV SOUTH FLORIDA·Filed 2020·Application pending·0 cites
- 2253US2007160615A1Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of Alzheimer's diseaseTAN JUN·Filed 2006·Application pending·0 cites
- 2352US9603869B2Lithium co-crystals and an additional neuropsychiatric agent for treatment of neuropsychiatric disordersTAN JUN·Filed 2016·Granted Mar 28, 2017·0 cites·13 claims
- 2452US9402870B2HUCBC treatment of amyloid associated diseaseTAN JUN·Filed 2010·Granted Aug 2, 2016·0 cites·11 claims
- 2550US2006223790A1Modulation of Microglial by Nicotinic MedicationsUNIV SOUTH FLORIDA·Filed 2006·Application pending·0 cites
- 2649US2010040558A1Green tea polyphenol alpha secretase enhancers and methods of useUNIV SOUTH FLORIDA·Filed 2006·Application pending·0 cites
- 2748US2005089939A1Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathologyFiled 2004·Application pending·0 cites
- 2848US2013165339A1Sapp-alpha as a biomarker for prediction of inflammatory and autoimmune-related disordersTAN JUN·Filed 2011·Application pending·0 cites
- 2947US9926354B2Amyloid precursor protein (APP) based Ã#-secretase inhibitor peptides, and methods of useUNIV SOUTH FLORIDA·Filed 2015·Granted Mar 27, 2018·0 cites·10 claims
- 3047US2008089905A1COMPOUNDS FOR STIMULATING STEM CELL PROLIFERATION INCLUDING AFA-OMEGA (EtOH)DAVIS SANBERG CYNDY·Filed 2007·Application pending·0 cites
- 3144US2017143769A1Human umbilical cord blood-derived monocytes for treatment of neurodegenerative diseases and disordersTAN JUN·Filed 2016·Application pending·0 cites
- 3243US2002137108A1CD45 isoform alteration in CD4+ T cells as a potential diagnostic marker in alzheimer's diseaseFiled 2001·Application pending·0 cites
- 3343US2004146949A1Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of alzheimer's diseaseTAN JUN·Filed 2003·Application pending·0 cites
- 3442US2013291135A1Transgenic model of alzheimer's diseaseTAN JUN·Filed 2013·Application pending·0 cites
- 3542US2008033038A1Compositions of polyphenols and methods of useSHYTLE R D·Filed 2007·Application pending·0 cites
- 3640US6787318B1Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathologyROSKAMP RES INST LLC·Filed 2000·Granted Sep 7, 2004·6 cites·12 claims
- 3740US2003077667A1Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of alzheimer's diseaseFiled 2002·Application pending·0 cites
- 3840US2010267733A1Synergistic Modulation of Microglial Activation by Nicotine and THCUNIV SOUTH FLORIDA·Filed 2010·Application pending·0 cites
- 3939US2011201565A1Luteolin and diosmin/diosmetin as novel stat3 inhibitors for treating autismUNIV SOUTH FLORIDA·Filed 2011·Application pending·0 cites
- 4037US10835759B2Methods, apparatuses, and systems for creating a patient-specific soft bolus for radiotherapy treatmentUNIV TEXAS·Filed 2018·Granted Nov 17, 2020·0 cites·30 claims
- 4137US2002102259A1Methods and compositions for stimulating CD 45 and thereby suppressing microglial activation associated with Alzheimer's diseaseFiled 2001·Application pending·0 cites
- 4237US2013217045A1Use of Functional Autoantibodies in Alzheimer DiseaseTAN JUN·Filed 2013·Application pending·0 cites
- 4336US2008085330A1Compounds for stimulating stem cell proliferation including spirulinaDAVIS SANBERG CYNDY·Filed 2007·Application pending·0 cites
- 4434US10149982B2Prevention and treatment of brain diseases and disorders related to abnormal protein aggregation through electromagnetic field treatmentARENDASH GARY W·Filed 2015·Granted Dec 11, 2018·0 cites·27 claims
- 4533US2019185544A1Compositions and methods of modulating abeta proteinSAWMILLER DARRELL·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jun Tan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →